|
|
|
11-50 employees
View all
|
|
biotechnology
|
|
Waltham,MA,US
|
|
Histogenics was acquired by Ocugen, (Nasdaq: OCGN) on September 27, 2019.Histogenics (Nasdaq: HSGX) is a leader in personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds a patient’s own knee cartilage, treating pain at the source and potentially preventing progression to osteoarthritis (OA). Read our community guidelines: https://goo.gl/Qtusgh
|
Histogenics Corporation Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Histogenics Corporation email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Histogenics Corporation customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.